tiprankstipranks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
DRUG
Bright Minds Biosciences
RESEARCH TOOLSreports

Bright Minds Biosciences (DRUG) Balance Sheet

280 Followers

Bright Minds Biosciences Balance Sheet

Bright Minds Biosciences's total assets for Q1 2026 were C$90.88M, an increase of 7.65% from the previous quarter. DRUG total liabilities were C$1.60M for the fiscal quarter, a -32.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Sep 25Dec 24Sep 23Sep 22Sep 21
Total Assets
C$ 84.42MC$ 6.10MC$ 6.88MC$ 12.09MC$ 20.04M
Total Liabilities
C$ 2.38MC$ 568.26KC$ 280.86KC$ 1.54MC$ 638.57K
Total Equity Gross Minority
C$ 82.04MC$ 5.54MC$ 6.60MC$ 10.54MC$ 19.40M
Other Metrics
Currency in CAD

Bright Minds Biosciences Debt to Assets